Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Advertisement
Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, is a clinical professor at Temple University (TU) School of Pharmacy and a clinical pharmacy specialist in infectious diseases at Temple University Hospital in Philadelphia, Pennsylvania. He also is director of the PGY2 Residency in Infectious Diseases Pharmacy at TU.
Articles by Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Dynavax and Vaxart Partner to Advance Oral COVID-19 Vaccine
2
Using Doxycycline for Post-Exposure Prevention of Lyme Disease in Young Kids
3
FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in Australia
4
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
5
